Total Payments
$5,658
2024 Payments
$18.01
Companies
17
Transactions
28
Medicare Patients
560
Medicare Billing
$52,146
Payment Breakdown by Category
Travel$4,830 (85.4%)
Food & Beverage$607.39 (10.7%)
Education$206.52 (3.7%)
Other$13.75 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $4,830 | 4 | 85.4% |
| Food and Beverage | $607.39 | 17 | 10.7% |
| Education | $206.52 | 6 | 3.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13.75 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bioverativ Therapeutics Inc. | $4,844 | 5 | $0 (2017) |
| Octapharma USA, Inc. | $283.11 | 4 | $0 (2023) |
| Genentech USA, Inc. | $131.42 | 2 | $0 (2018) |
| BioMarin Pharmaceutical Inc. | $60.00 | 2 | $0 (2020) |
| CSL Behring | $55.00 | 1 | $0 (2019) |
| Biogen, Inc. | $47.30 | 1 | $0 (2017) |
| Rigel Pharmaceuticals, Inc. | $39.44 | 2 | $0 (2018) |
| Novo Nordisk Inc | $32.78 | 2 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $30.29 | 1 | $0 (2023) |
| Z-Medica, LLC | $22.72 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.01 | 1 | PharmaEssentia USA Corporation ($18.01) |
| 2023 | $105.80 | 2 | Octapharma USA, Inc. ($75.51) |
| 2021 | $13.93 | 1 | Acrotech Biopharma LLC ($13.93) |
| 2020 | $72.75 | 3 | BioMarin Pharmaceutical Inc. ($60.00) |
| 2019 | $168.24 | 4 | Octapharma USA, Inc. ($95.01) |
| 2018 | $264.29 | 9 | Genentech USA, Inc. ($131.42) |
| 2017 | $5,015 | 8 | Bioverativ Therapeutics Inc. ($4,844) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 09/05/2023 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Education | Cash or cash equivalent | $30.29 | General |
| Category: Hematology | ||||||
| 06/26/2023 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $75.51 | General |
| Category: COAGULATION | ||||||
| 09/08/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ADVATE (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: HEMATOLOGY | ||||||
| 06/16/2020 | BioMarin Pharmaceutical Inc. | — | Education | In-kind items and services | $30.00 | General |
| 06/16/2020 | BioMarin Pharmaceutical Inc. | — | Education | In-kind items and services | $30.00 | General |
| 10/08/2019 | CSL Behring | Idelvion (Biological) | Education | In-kind items and services | $55.00 | General |
| Category: Hematology | ||||||
| 05/13/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.23 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Octapharma USA, Inc. | NUWIQ (Biological) | Food and Beverage | In-kind items and services | $83.50 | General |
| Category: COAGULATION | ||||||
| 05/09/2019 | Octapharma USA, Inc. | WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: COAGULATION | ||||||
| 12/13/2018 | Bayer HealthCare Pharmaceuticals Inc. | Jivi (Drug), Kovaltry | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Hematology | ||||||
| 12/05/2018 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Hematology | ||||||
| 12/05/2018 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Hematology | ||||||
| 10/03/2018 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 08/03/2018 | Z-Medica, LLC | QuikClot (Device), Control+ | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: Bleeding control | ||||||
| 03/29/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $15.27 | General |
| 03/28/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $116.15 | General |
| 03/01/2018 | Novo Nordisk Inc | REBINYN (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Hemophilia | ||||||
| 02/22/2018 | Novo Nordisk Inc | NovoSeven RT (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Hemophilia | ||||||
| 07/09/2017 | Octapharma USA, Inc. | OCTAGENATE (Biological) | Food and Beverage | In-kind items and services | $112.59 | General |
| Category: COAGULATION | ||||||
| 05/15/2017 | Bioverativ Therapeutics Inc. | — | Travel and Lodging | Cash or cash equivalent | $4,770.00 | General |
| 05/15/2017 | Bioverativ Therapeutics Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13.75 | General |
| 03/27/2017 | Bioverativ Therapeutics Inc. | — | Travel and Lodging | Cash or cash equivalent | $25.99 | General |
| 03/27/2017 | Bioverativ Therapeutics Inc. | — | Travel and Lodging | Cash or cash equivalent | $23.87 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 148 | 187 | $45,138 | $14,339 |
| 2022 | 6 | 108 | 135 | $18,839 | $7,255 |
| 2021 | 9 | 179 | 242 | $41,430 | $19,181 |
| 2020 | 7 | 125 | 185 | $29,890 | $11,370 |
Total Patients
560
Total Services
749
Medicare Billing
$52,146
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 52 | $15,137 | $3,659 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 24 | 24 | $8,261 | $3,389 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 21 | $6,471 | $2,016 | 31.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $4,202 | $1,832 | 43.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 33 | $2,136 | $1,280 | 59.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 27 | $5,927 | $1,227 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,004 | $936.63 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 42 | $5,697 | $1,902 | 33.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $3,929 | $1,862 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 21 | $4,124 | $1,472 | 35.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 20 | $2,332 | $1,062 | 45.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 20 | $1,294 | $556.75 | 43.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 17 | 20 | $1,463 | $399.55 | 27.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 25 | 38 | $8,813 | $4,077 | 46.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 51 | $8,772 | $3,863 | 44.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 39 | $4,547 | $2,227 | 49.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $4,638 | $2,070 | 44.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $3,929 | $1,909 | 48.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 14 | $3,097 | $1,511 | 48.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 18 | $3,027 | $1,477 | 48.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 38 | $2,459 | $1,129 | 45.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 18 | $2,148 | $917.83 | 42.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 21 | 36 | $6,192 | $2,150 | 34.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 19 | 28 | $6,493 | $2,110 | 32.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 18 | $3,981 | $1,984 | 49.8% |
About Dr. Peter Kouides, M.D
Dr. Peter Kouides, M.D is a Hematology & Oncology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780638775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Kouides, M.D has received a total of $5,658 in payments from pharmaceutical and medical device companies, with $18.01 received in 2024. These payments were reported across 28 transactions from 17 companies. The most common payment nature is "Travel and Lodging" ($4,830).
As a Medicare-enrolled provider, Kouides has provided services to 560 Medicare beneficiaries, totaling 749 services with total Medicare billing of $52,146. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Rochester, NY
- Active Since 05/22/2006
- Last Updated 06/17/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780638775
Products in Payments
- OCTAGENATE (Biological) $112.59
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) $87.02
- NUWIQ (Biological) $83.50
- Idelvion (Biological) $55.00
- ALPROLIX (Biological) $47.30
- Tavalisse (Drug) $39.44
- Empaveli (Drug) $30.29
- QuikClot (Device) $22.72
- Jivi (Drug) $18.97
- VYXEOS (Drug) $18.96
- OPDIVO (Biological) $18.23
- BESREMI (Drug) $18.01
- REBINYN (Drug) $16.78
- NovoSeven RT (Drug) $16.00
- BELEODAQ (Drug) $13.93
- ADVATE (Biological) $12.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Rochester
Dr. Alex Spyropoulos, Md, MD
Hematology & Oncology — Payments: $750,882
Hematology & Oncology $750,882
Shaji Kumar, M.d, M.D
Hematology & Oncology — Payments: $722,278
Hematology & Oncology $722,278
David Dingli, M.d, M.D
Hematology & Oncology — Payments: $505,158
Hematology & Oncology $505,158
Amit Mahipal
Hematology & Oncology — Payments: $474,204
Hematology & Oncology $474,204
Yi Lin, M.d, M.D
Hematology & Oncology — Payments: $333,310
Hematology & Oncology $333,310
Grzegorz Nowakowski, M.d, M.D
Hematology & Oncology — Payments: $254,028
Hematology & Oncology $254,028